The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An FDA analysis of the association between adverse events and outcome in patients with urothelial cancer receiving a programmed death protein 1 or programmed death ligand 1 (anti-PD-1/L1) antibody.
 
Chana Weinstock
No Relationships to Disclose
 
Virginia Ellen Maher
No Relationships to Disclose
 
Laura L. Fernandes
No Relationships to Disclose
 
Shenghui Tang
No Relationships to Disclose
 
Sundeep Agrawal
No Relationships to Disclose
 
Michael Holman Brave
No Relationships to Disclose
 
Yang-Min Ning
No Relationships to Disclose
 
Harpreet Singh
No Relationships to Disclose
 
Daniel L. Suzman
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; GE Healthcare; Trillium Therapeutics
Honoraria - Grand Rounds Health
 
James Xu
No Relationships to Disclose
 
Kirsten B. Goldberg
No Relationships to Disclose
 
Rajeshwari Sridhara
No Relationships to Disclose
 
Amna Ibrahim
No Relationships to Disclose
 
Marc Robert Theoret
No Relationships to Disclose
 
Julia A. Beaver
No Relationships to Disclose
 
Richard Pazdur
No Relationships to Disclose